ADDPI 2018_07 INADA vs Simarjit Kaur

In February 2018 the India National Anti-Doping Agency (INADA) has reported an anti-doping rule violation against the Athlete Simarjit Kaur after her sample tested positive for the prohibited substance Meldonium.
After notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).

The Athlete stated that she had used supplements during training and prescribed medication as treatment for her injury. She could not explain how the substance entered her system and when requested she could not produce the supplements in question because they were not available anymore.

The Panel finds that the Athlete had used supplements without any research or consultation of any expert before using. The Panel deems that she failed to establish how the substance entered her system nor that the violation was not intentional.

Therefore the ADDPI decides on 3 October 2018 to impose a 4 year period of ineligibility on the Athlete starting on de date of the provisional suspension, i.e. on 6 February 2018.

Original document

Parameters

Legal Source
National Decisions
Date
3 October 2018
Arbitrator
Kumar, Sanjeev
Singh, Jagbir
Singh, Kuldeep
Original Source
India National Anti-Doping Agency (INADA)
Country
India
Language
English
ADRV
Adverse Analytical Finding / presence
Sport/IFs
Athletics (WA) - World Athletics
Other organisations
Anti-Doping Disciplinary Panel of India (ADDPI)
India National Anti-Doping Agency (INADA)
Laboratories
New Delhi, India: National Dope Testing Laboratory
Doping classes
S4. Hormone And Metabolic Modulators
Substances
Meldonium
Medical terms
Treatment / self-medication
Various
Supplements
Document type
Pdf file
Date generated
27 November 2018
Date of last modification
17 January 2019
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin